Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer

This publication has 22 references indexed in Scilit:

• Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer
  Lung Cancer, 1999
• Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise
  British Journal of Cancer, 1999
• Interpreting the significance of changes in health-related quality-of-life scores.
  Journal of Clinical Oncology, 1998
• Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
  European Journal Of Cancer, 1996
• Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.
  Journal of Clinical Oncology, 1994
• The EORTC Modular Approach to Quality of Life Assessment in Oncology
  International Journal of Mental Health, 1994
• The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
  European Journal Of Cancer, 1994
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993
• Chemotherapy of Lung Cancer
  New England Journal of Medicine, 1992
• Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin
  International Journal of Radiation Oncology*Biology*Physics, 1991